Cencora, Inc. (COR) witnessed strong momentum in the year-to-date period. Shares of the company have rallied 13.2% compared with 3.7% growth of the industry. The S&P 500 Composite has risen 7.4% during the same time frame.With healthy fundamentals and strong growth opportunities, this Zacks Rank #3 (Hold) company appears to be a solid wealth creator for its investors at the moment.Chesterbrook, PA-based Cencora is one of the world’s largest pharmaceutical services companies, which focuses on providing drug ...